Christina Applegate, known for her Emmy-winning acting career, has recently revealed that her neurologist no longer believes she has multiple sclerosis (MS), a diagnosis she had lived with for five years. This development comes after Applegate publicly shared her experience living with MS through her memoir and the podcast MeSsy, which she co-hosts with fellow actor Jamie Lynn Sigler. While some may view the change in diagnosis as positive, Applegate has expressed that this "undianosis" is not relief, as she continues to face significant health challenges without clear explanations.

Multiple sclerosis is a complex neurological condition that affects the brain and central nervous system. Despite advances in diagnostic methods, misdiagnosis remains a significant concern. A 2024 systematic review found that approximately 15% of MS diagnoses studied were incorrect, with women being twice as likely as men to receive a false diagnosis of the disease. Conversely, underdiagnosis is also a common issue, with many patients experiencing prolonged delays before receiving accurate identification and treatment.

Applegate’s case aligns with these broader patterns of diagnostic uncertainty faced by many people living with complex neurological symptoms. Medical professionals emphasize that most patients undergoing treatment for MS can be confident in their diagnosis, but they also recommend reassessment for anyone with lingering doubts about the accuracy of their condition.

Personal accounts illustrate the difficulties and frustrations associated with the diagnostic process. One individual shared her experience of being misdiagnosed with bipolar disorder for many years before a correct MS diagnosis. Initially referred to psychiatry after trauma and severe panic attacks, she was treated with psychiatric medications that failed to halt her physical decline. Despite worsening symptoms, her concerns were repeatedly dismissed as psychiatric in origin, a response she identified as being influenced by gender biases.

The turning point came only after a second neurologist performed an MRI scan, which showed abnormalities consistent with MS. The individual noted that her health improved significantly once the correct diagnosis was made and MS-specific treatments began. She highlights the distress caused not only by the disease itself but also by the prolonged period of uncertainty and misdiagnosis, which can carry significant emotional and social consequences, including stigma and difficulties accessing support services.

Both Applegate’s and others’ experiences underscore the challenges in the boundary between diagnosis and nondiagnosis of complex illnesses like MS. They call attention to the need for more careful, empathetic evaluation of symptoms and caution against dismissing patients’ concerns on the basis of gender or other biases. As medical understanding evolves, healthcare providers and systems face ongoing pressure to improve accuracy and reduce the substantial personal and societal burdens associated with diagnostic errors in neurological diseases.